These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 16629559)
1. The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. Vignaroli E; Pace EA; Willey J; Palmer JL; Zhang T; Bruera E J Palliat Med; 2006 Apr; 9(2):296-303. PubMed ID: 16629559 [TBL] [Abstract][Full Text] [Related]
2. The utility of the Edmonton Symptom Assessment System in screening for anxiety and depression. Bagha SM; Macedo A; Jacks LM; Lo C; Zimmermann C; Rodin G; Li M Eur J Cancer Care (Engl); 2013 Jan; 22(1):60-9. PubMed ID: 22694595 [TBL] [Abstract][Full Text] [Related]
4. The Edmonton Symptom Assessment System (ESAS) as a screening tool for depression and anxiety in non-advanced patients with solid or haematological malignancies on cure or follow-up. Ripamonti CI; Bandieri E; Pessi MA; Maruelli A; Buonaccorso L; Miccinesi G Support Care Cancer; 2014 Mar; 22(3):783-93. PubMed ID: 24276952 [TBL] [Abstract][Full Text] [Related]
5. Frequency of reporting and predictive factors for anxiety and depression in patients with advanced cancer. Salvo N; Zeng L; Zhang L; Leung M; Khan L; Presutti R; Nguyen J; Holden L; Culleton S; Chow E Clin Oncol (R Coll Radiol); 2012 Mar; 24(2):139-48. PubMed ID: 21652191 [TBL] [Abstract][Full Text] [Related]
6. Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Delgado-Guay M; Parsons HA; Li Z; Palmer JL; Bruera E Support Care Cancer; 2009 May; 17(5):573-9. PubMed ID: 19005686 [TBL] [Abstract][Full Text] [Related]
7. Frequency of anxiety and depression and screening performance of the Edmonton Symptom Assessment Scale in a psycho-oncology clinic. Valentine A; Brown J; Lacourt T; Chen M; De La Garza R; Bruera E Psychooncology; 2022 Feb; 31(2):290-297. PubMed ID: 34546618 [TBL] [Abstract][Full Text] [Related]
8. Screening for anxiety and depression in dialysis patients: comparison of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory. Preljevic VT; Ă˜sthus TB; Sandvik L; Opjordsmoen S; Nordhus IH; Os I; Dammen T J Psychosom Res; 2012 Aug; 73(2):139-44. PubMed ID: 22789418 [TBL] [Abstract][Full Text] [Related]
9. Association between self-reported sleep disturbance and other symptoms in patients with advanced cancer. Delgado-Guay M; Yennurajalingam S; Parsons H; Palmer JL; Bruera E J Pain Symptom Manage; 2011 May; 41(5):819-27. PubMed ID: 21306864 [TBL] [Abstract][Full Text] [Related]
10. Use of the hospital anxiety and depression scale as a screening tool for patients with headache. Juang KD; Wang SJ; Lin CH; Fuh JL Zhonghua Yi Xue Za Zhi (Taipei); 1999 Nov; 62(11):749-55. PubMed ID: 10575802 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of screening instruments for depression and anxiety in breast cancer survivors. Alexander S; Palmer C; Stone PC Breast Cancer Res Treat; 2010 Jul; 122(2):573-8. PubMed ID: 19960243 [TBL] [Abstract][Full Text] [Related]
12. Errors in symptom intensity self-assessment by patients receiving outpatient palliative care. Garyali A; Palmer JL; Yennurajalingam S; Zhang T; Pace EA; Bruera E J Palliat Med; 2006 Oct; 9(5):1059-65. PubMed ID: 17040143 [TBL] [Abstract][Full Text] [Related]
13. Reliability and validity of a Chinese version of the HADS for screening depression and anxiety in psycho-cardiological outpatients. Yang Y; Ding R; Hu D; Zhang F; Sheng L Compr Psychiatry; 2014 Jan; 55(1):215-20. PubMed ID: 24199886 [TBL] [Abstract][Full Text] [Related]
14. Student anxiety and depression: comparison of questionnaire and interview assessments. Andrews B; Hejdenberg J; Wilding J J Affect Disord; 2006 Oct; 95(1-3):29-34. PubMed ID: 16764939 [TBL] [Abstract][Full Text] [Related]
15. The Accuracy of the Edmonton Symptom Assessment System for the Assessment of Depression in Patients With Cancer: A Systematic Review and Meta-Analysis. Boonyathee S; Nagaviroj K; Anothaisintawee T Am J Hosp Palliat Care; 2018 Apr; 35(4):731-739. PubMed ID: 29186983 [TBL] [Abstract][Full Text] [Related]
16. [The accuracy of HADS and GHQ-12 in detecting psychiatric morbidity in breast cancer patients]. Krespi Boothby MR; Hill J; Holcombe C; Clark L; Fisher J; Salmon P Turk Psikiyatri Derg; 2010; 21(1):49-59. PubMed ID: 20204904 [TBL] [Abstract][Full Text] [Related]
17. Screening for depression and anxiety disorders in primary care patients. Bunevicius A; Peceliuniene J; Mickuviene N; Valius L; Bunevicius R Depress Anxiety; 2007; 24(7):455-60. PubMed ID: 17117433 [TBL] [Abstract][Full Text] [Related]
18. Screening cancer patients' families with the distress thermometer (DT): a validation study. Zwahlen D; Hagenbuch N; Carley MI; Recklitis CJ; Buchi S Psychooncology; 2008 Oct; 17(10):959-66. PubMed ID: 18203146 [TBL] [Abstract][Full Text] [Related]
19. Validation of the French Version of the Edmonton Symptom Assessment System. Pautex S; Vayne-Bossert P; Bernard M; Beauverd M; Cantin B; Mazzocato C; Thollet C; Bollondi-Pauly C; Ducloux D; Herrmann F; Escher M J Pain Symptom Manage; 2017 Nov; 54(5):721-726.e1. PubMed ID: 28751077 [TBL] [Abstract][Full Text] [Related]
20. [Occurrence of anxiety and depression disorders after acute cardiac events during hospital rehabilitation. Application of the Hospital Anxiety and Depression Scale as a screening instrument]. Tiringer I; Simon A; Herrfurth D; Suri I; Szalai K; Veress A Psychiatr Hung; 2008; 23(6):430-43. PubMed ID: 19218625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]